Yıl: 2021 Cilt: 59 Sayı: 2 Sayfa Aralığı: 133 - 138 Metin Dili: İngilizce DOI: 10.4274/haseki.galenos.2021.6749 İndeks Tarihi: 21-05-2021

The Effect of Chronic Glucocorticoid Exposure on Brown Adipose Tissue in Cushing’s Disease

Öz:
Aim: In this study, we aimed to evaluate the levels of brown adipose tissue markers uncoupling protein-1 (UCP-1), irisin, bonemorphogenetic protein-7 (BMP-7) and PR-Domain Zinc Finger Protein-16 (PRDM-16) in Cushing’s disease (CH) with hypercortisolism.Methods: The study was conducted prospectively with 48 CH patients and 40 healthy volunteers between 2018 and 2019. Two ccof peripheral blood taken from the participants was centrifuged and stored at -80 oC degrees. Cushing’s syndrome was excluded byperforming 1 mg dexamethasone suppression test in the control group. Blood samples were analyzed by Enzyme-linked ImmunosorbentAssay method.Results: The patient group included 11 males (22.9%), 37 female (77.1%); 9 male (22.5%) and 31 females (77.5%) in the controlgroup. Body mass index was 31.29±5.76 kg/m2 in the patient group and 33.42±3.11 kg/m2 in the control group. PRDM-16, Irisin, BMP-7, UCP-1 levels were not significantly different between the two groups. While there was a positive correlation between serum cortisoland irisin, a negative correlation was observed between urinary free cortisol and UCP-1.Conclusion: These data suggest that long-term exposure to high doses of glucocorticoids in CH patients causes loss of adipose tissuefunctionality and development of resistance in vivo.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing’s syndrome. Lancet 2015;386:913-27.
  • 2. Lee P, Swarbrick MM, Ho KK. Brown adipose tissue in adult humans: a metabolic renaissance. Endocr Rev 2013;34:413- 38.
  • 3. Carpentier AC, Blondin DP, Virtanen KA, Richard D, Haman F, Turcotte ÉE. Brown Adipose Tissue Energy Metabolism in Humans. Front Endocrinol (Lausanne) 2018;9:447.
  • 4. Zhang Y, Xie C, Wang H, et al. Irisin exerts dual effects on browning and adipogenesis of human white adipocytes. Am J Physiol Endocrinol Metab 2016;311:530-41.
  • 5. Tseng YH, Kokkotou E, Schulz TJ, et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 2008;454:1000-4.
  • 6. Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential. Nat Med 2013;19:1252-63.
  • 7. Barclay JL, Agada H, Jang C, Ward M, Wetzig N, Ho KK. Effects of glucocorticoids on human brown adipocytes. J Endocrinol 2015;224:139-47.
  • 8. Strack AM, Bradbury MJ, Dallman MF. Corticosterone decreases nonshivering thermogenesis and increases lipid storage in brown adipose tissue. Am J Physiol 1995;268:183- 91.
  • 9. Nieman LK, Biller BM, Findling JW, et al. Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2015;100:2807-31.
  • 10. Rockall AG, Sohaib SA, Evans D, et al. Computed tomography assessment of fat distribution in male and female patients with Cushing’s syndrome. Eur J Endocrinol 2003;149:561-7.
  • 11. Infante M, Armani A, Mammi C, Fabbri A, Caprio M. Impact of Adrenal Steroids on Regulation of Adipose Tissue. Compr Physiol 2017;7:1425-47.
  • 12. Feldman D. Evidence that brown adipose tissue is a glucocorticoid target organ. Endocrinology 1978;103:2091-7.
  • 13. Mousovich-Neto F, Matos MS, Costa ACR, et al. Brown adipose tissue remodelling induced by corticosterone in male Wistar rats. Exp Physiol 2019;104:514-28.
  • 14. van den Beukel JC, Grefhorst A, et al. Direct activating effects of adrenocorticotropic hormone (ACTH) on brown adipose tissue are attenuated by corticosterone. FASEB J 2014;28:4857-67.
  • 15. Biswas HM. Effect of adrenocorticotropic hormone on UCP1 gene expression in brown adipocytes. J Basic Clin Physiol Pharmacol 2017;28:267-74.
  • 16. Schnabl K, Westermeier J, Li Y, Klingenspor M. Opposing Actions of Adrenocorticotropic Hormone and Glucocorticoids on UCP1-Mediated Respiration in Brown Adipocytes. Front Physiol 2019;9:1931.
  • 17. Iwen KA, Senyaman O, Schwartz A, et al. Melanocortin crosstalk with adipose functions: ACTH directly induces insulin resistance, promotes a pro-inflammatory adipokine profile and stimulates UCP-1 in adipocytes. J Endocrinol 2008;196:465-72.
  • 18. Rothwell NJ, Stock MJ. Acute and chronic effects of ACTH on thermogenesis and brown adipose tissue in the rat. Comp Biochem Physiol A Comp Physiol 1985;81:99-102.
  • 19. Luijten IHN, Cannon B, Nedergaard J. Glucocorticoids and Brown Adipose Tissue: Do glucocorticoids really inhibit thermogenesis? Mol Aspects Med 2019;68:42-59.
  • 20. FAWCETT DW, JONES IC. The effects of hypophysectomy, adrenalectomy and of thiouracil feeding on the cytology of brown adipose tissue. Endocrinology 1949;45:609-21.
  • 21. LACHANCE J, PAGE E. Hormonal factors influencing fat deposition in the interscapular brown adipose tissue of the white rat. Endocrinology 1953;52:57-64.
  • 22. Yukimura Y, Bray GA, Wolfsen AR. Some effects of adrenalectomy in the fatty rat. Endocrinology 1978;103:1924- 8.
  • 23. Luijten IHN, Brooks K, Boulet N, et al. Glucocorticoid Induced Obesity Develops Independently of UCP1. Cell Rep 2019;27:1686-98.
  • 24. Betz MJ, Slawik M, Lidell ME, et al. Presence of brown adipocytes in retroperitoneal fat from patients with benign adrenal tumors: relationship with outdoor temperature. J Clin Endocrinol Metab 2013;98:4097-104.
  • 25. Ramage LE, Akyol M, Fletcher AM, et al. Glucocorticoids Acutely Increase Brown Adipose Tissue Activity in Humans, Revealing Species-Specific Differences in UCP-1 Regulation. Cell Metab 2016;24:130-41.
  • 26. Chen N, Li Q, Liu J, Jia S. Irisin, an exercise-induced myokine as a metabolic regulator: an updated narrative review. Diabetes Metab Res Rev 2016;32:51-9.
  • 27. Choi HY, Kim S, Park JW, et al. Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans. J Clin Endocrinol Metab 2014;99:2778-85.
  • 28. Guarnotta V, Prinzi A, Pitrone M, Pizzolanti G, Giordano C. Circulating Irisin Levels as a Marker of Osteosarcopenic Obesity in Cushing’s Disease. Diabetes Metab Syndr Obes 2020;13:1565-74.
  • 29. Tseng YH, Cypess AM, Kahn CR. Cellular bioenergetics as a target for obesity therapy. Nat Rev Drug Discov 2010;9:465- 82.
  • 30. Kontani Y, Wang Y, Kimura K, et al. UCP1 deficiency increases susceptibility to diet-induced obesity with age. Aging Cell 2005;4:147-55.
  • 31. Al Amrani A, AbdelKarim M, AlZoghaibi M. PRDM16 Gene Polymorphism Is Associated with Obesity and Blood Lipids Profiles in Saudi Population. J Clin Med 2018;7:141.
  • 32. Zamani N, Brown CW. Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditure. Endocr Rev 2011;32:387-403.
APA SELEK A, sözen m, çayır b, Tarkun İ, çetinarslan b, canturk z, Gezer E, köksalan d (2021). The Effect of Chronic Glucocorticoid Exposure on Brown Adipose Tissue in Cushing’s Disease. , 133 - 138. 10.4274/haseki.galenos.2021.6749
Chicago SELEK ALEV,sözen mehmet,çayır berat furkan,Tarkun İlhan,çetinarslan berrin,canturk zeynep,Gezer Emre,köksalan damla The Effect of Chronic Glucocorticoid Exposure on Brown Adipose Tissue in Cushing’s Disease. (2021): 133 - 138. 10.4274/haseki.galenos.2021.6749
MLA SELEK ALEV,sözen mehmet,çayır berat furkan,Tarkun İlhan,çetinarslan berrin,canturk zeynep,Gezer Emre,köksalan damla The Effect of Chronic Glucocorticoid Exposure on Brown Adipose Tissue in Cushing’s Disease. , 2021, ss.133 - 138. 10.4274/haseki.galenos.2021.6749
AMA SELEK A,sözen m,çayır b,Tarkun İ,çetinarslan b,canturk z,Gezer E,köksalan d The Effect of Chronic Glucocorticoid Exposure on Brown Adipose Tissue in Cushing’s Disease. . 2021; 133 - 138. 10.4274/haseki.galenos.2021.6749
Vancouver SELEK A,sözen m,çayır b,Tarkun İ,çetinarslan b,canturk z,Gezer E,köksalan d The Effect of Chronic Glucocorticoid Exposure on Brown Adipose Tissue in Cushing’s Disease. . 2021; 133 - 138. 10.4274/haseki.galenos.2021.6749
IEEE SELEK A,sözen m,çayır b,Tarkun İ,çetinarslan b,canturk z,Gezer E,köksalan d "The Effect of Chronic Glucocorticoid Exposure on Brown Adipose Tissue in Cushing’s Disease." , ss.133 - 138, 2021. 10.4274/haseki.galenos.2021.6749
ISNAD SELEK, ALEV vd. "The Effect of Chronic Glucocorticoid Exposure on Brown Adipose Tissue in Cushing’s Disease". (2021), 133-138. https://doi.org/10.4274/haseki.galenos.2021.6749
APA SELEK A, sözen m, çayır b, Tarkun İ, çetinarslan b, canturk z, Gezer E, köksalan d (2021). The Effect of Chronic Glucocorticoid Exposure on Brown Adipose Tissue in Cushing’s Disease. Haseki Tıp Bülteni, 59(2), 133 - 138. 10.4274/haseki.galenos.2021.6749
Chicago SELEK ALEV,sözen mehmet,çayır berat furkan,Tarkun İlhan,çetinarslan berrin,canturk zeynep,Gezer Emre,köksalan damla The Effect of Chronic Glucocorticoid Exposure on Brown Adipose Tissue in Cushing’s Disease. Haseki Tıp Bülteni 59, no.2 (2021): 133 - 138. 10.4274/haseki.galenos.2021.6749
MLA SELEK ALEV,sözen mehmet,çayır berat furkan,Tarkun İlhan,çetinarslan berrin,canturk zeynep,Gezer Emre,köksalan damla The Effect of Chronic Glucocorticoid Exposure on Brown Adipose Tissue in Cushing’s Disease. Haseki Tıp Bülteni, vol.59, no.2, 2021, ss.133 - 138. 10.4274/haseki.galenos.2021.6749
AMA SELEK A,sözen m,çayır b,Tarkun İ,çetinarslan b,canturk z,Gezer E,köksalan d The Effect of Chronic Glucocorticoid Exposure on Brown Adipose Tissue in Cushing’s Disease. Haseki Tıp Bülteni. 2021; 59(2): 133 - 138. 10.4274/haseki.galenos.2021.6749
Vancouver SELEK A,sözen m,çayır b,Tarkun İ,çetinarslan b,canturk z,Gezer E,köksalan d The Effect of Chronic Glucocorticoid Exposure on Brown Adipose Tissue in Cushing’s Disease. Haseki Tıp Bülteni. 2021; 59(2): 133 - 138. 10.4274/haseki.galenos.2021.6749
IEEE SELEK A,sözen m,çayır b,Tarkun İ,çetinarslan b,canturk z,Gezer E,köksalan d "The Effect of Chronic Glucocorticoid Exposure on Brown Adipose Tissue in Cushing’s Disease." Haseki Tıp Bülteni, 59, ss.133 - 138, 2021. 10.4274/haseki.galenos.2021.6749
ISNAD SELEK, ALEV vd. "The Effect of Chronic Glucocorticoid Exposure on Brown Adipose Tissue in Cushing’s Disease". Haseki Tıp Bülteni 59/2 (2021), 133-138. https://doi.org/10.4274/haseki.galenos.2021.6749